methylene blue and semaglutide New Programs Methylene Blue Safe: Evidence-Based Clinical

Both medications belong to the GLP-1 receptor agonist class, but they work differently at the molecular level

The most common effects are mild nausea, upset stomach, bloating, and changes in bowel habits, especially when starting or raising the dose

Results of this study suggest a modest increase in the risk of NAION among individuals with type 2 diabetes associated with semaglutide use, smaller than that previously reported, and warranting further investigation into the clinical implications of this association, the study concluded

It is recommended that a low-calorie diet and physical activity is used with the medication